Re­call re­port: Apo­tex re­calls 2 batch­es of blood-thin­ner in­jec­tion af­ter sy­ringe mis­la­bel­ing sna­fu

Drug re­calls are an ug­ly busi­ness, par­tic­u­lar­ly be­cause they’re of­ten tied to drug­mak­ers mak­ing hard-to-miss mis­takes. In the case of Cana­di­an gener­ics mak­er Apo­tex, a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.